This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Cosentyx
  • /
  • Judging the Efficacy of Secukinumab in Patients Wi...
Clinical trial

Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) (JUNCTURE)

Read time: 2 mins
Last updated:1st Oct 2012
Identifier: NCT01636687
The purpose of this study is to demonstrate efficacy of autoinjector administered secukinumab at Week 12 based on PASI and IGA response rates versus placebo in subjects with moderate to severe chronic plaque-type psoriasis.

 

Category Value
Study type(s) Interventional
Expected enrolment 182
Study start date 2012-10-01
Estimated primary completion date 2016-10-01

View full details